No-reflow phenomenon in the heart and brain

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 315, Issue 3, 2018, Pages H550-H562

  Kloner, Robert A ^a,b   King, Kevin S ^a   Harrington, Michael G ^a,b  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Acute myocardial infarction; Cerebrovascular accident; Ischemia reperfusion injury; No reflow phenomenon; Reperfusion; Stroke

Indexed keywords

BIOLOGICAL MARKER;

BRAIN BLOOD VOLUME; BRAIN ISCHEMIA; CLINICAL OUTCOME; CLINICAL STUDY; CORONARY ARTERY OCCLUSION; ERYTHROCYTE AGGREGATION; HEART FAILURE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FUNCTION; HUMAN; NO REFLOW PHENOMENON; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ANIMAL; BRAIN; CORONARY BLOOD VESSEL; HEART; PATHOPHYSIOLOGY; VASCULARIZATION;

ANIMALS; BRAIN; CORONARY VESSELS; HEART; HUMANS; NO-REFLOW PHENOMENON;

EID: 85052393133     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00183.2018     Document Type: Review

References (132)

1. Abela GS, Kalavakunta JK, Janoudi A, Leffler D, Dhar G, Salehi N, Cohn J, Shah I, Karve M, Kotaru VP, Gupta V, David S, Narisetty KK, Rich M, Vanderberg A, Pathak DR, Shamoun FE. Frequency of cholesterol crystals in culprit coronary artery aspirate during acute myocardial infarction and their relation to inflammation and myocardial injury. Am J Cardiol 120: 1699–1707, 2017. doi:10.1016/j.amjcard. 2017.07.075.
2. Abu Arab T, Rafik R, El Etriby A. Efficacy and safety of local intracoronary drug delivery in treatment of no-reflow phenomenon: a pilot study. J Interv Cardiol 29: 496–504, 2016. doi:10.1111/joic.12318.
3. 3 inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia. Stroke 31: 1402–1410, 2000. doi:10.1161/str.31.6.1402.
4. Aitmokhtar O, Paganelli F, Benamara S, Azaza A, Bonello L, Hamza O, Seddiki S, Benathmane T, Saidane M, Bouzid A, Kara M, Sik A, Azzouz A, Harbi F, Monsuez JJ, Benkhedda S. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Arch Cardiovasc Dis 110: 626–633, 2017. doi:10.1016/j. acvd.2016.12.017.
5. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378: 708–718, 2018. doi:10.1056/NEJMoa1713973.
6. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80: 1846–1861, 1989. doi:10.1161/01.CIR.80.6.1846.
7. Ames A III, Gurian BS. Effects of glucose and oxygen deprivation on function of isolated mammalian retina. J Neurophysiol 26: 617–634, 1963. doi:10.1152/jn.1963.26.4.617.
8. Ames A III, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol 52: 437–453, 1968.
9. + at critical levels of brain ischemia. Stroke 8: 51–57, 1977. doi:10.1161/str.8.1.13521.
10. Ayata C, Lauritzen M. Spreading depression, spreading depolarizations, and the cerebral vasculature. Physiol Rev 95: 953–993, 2015. doi:10.1152/physrev.00027.2014.
11. Balta S, Celik T, Ozturk C, Kaya MG, Aparci M, Yildirim AO, Demir M, Kilic S, Aydin İ, Iyisoy A. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction. Am J Emerg Med 34: 1542– 1547, 2016. doi:10.1016/j.ajem.2016.05.031.
12. Bayramoglu A, Tasolar H, Kaya A, Tanboga IH, Yaman M, Bektas O, Gunaydin ZY, Oduncu V. Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients. J Interv Cardiol 31: 144–149, 2018. doi:10.1111/joic.12463.
13. Bessonov IS, Kuznetsov VA, Potolinskaya YV, Zyrianov IP, Sapo-zhnikov SS. [Impact of hyperglycemia on the results of percutaneous coronary interventions in patients with acute ST-segment elevation myocardial infarction]. Ter Arkh 89: 25–29, 2017. doi:10.17116/terarkh201789925-29.
14. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 109: 1121–1126, 2004. doi:10.1161/01.CIR.0000118496.44135.A7.
15. Bosetti F, Galis ZS, Bynoe MS, Charette M, Cipolla MJ, Del Zoppo GJ, Gould D, Hatsukami TS, Jones TL, Koenig JI, Lutty GA, Maric-Bilkan C, Stevens T, Tolunay HE, Koroshetz W; “Small Blood Vessels: Big Health Problems” Workshop Participants. “Small Blood Vessels: Big Health Problems?”: scientific recommendations of the National Institutes of Health Workshop. J Am Heart Assoc 5: e004389, 2016. doi:10.1161/JAHA.116.004389.
16. Botto N, Sbrana S, Trianni G, Andreassi MG, Ravani M, Rizza A, Al-Jabri A, Palmieri C, Berti S. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for “no-reflow” phenomenon? Int J Cardiol 117: 123–130, 2007. doi:10.1016/j.ijcard.2006.04.060.
17. Burrows FE, Bray N, Denes A, Allan SM, Schiessl I. Delayed reperfusion deficits after experimental stroke account for increased pathophysiology. J Cereb Blood Flow Metab 35: 277–284, 2015. doi:10.1038/jcbfm.2014.197.
18. Cenko E, Ricci B, Kedev S, Kalpak O, Câlmâc L, Vasiljevic Z, Knežević B, Dilic M, Miličić D, Manfrini O, Koller A, Dorobantu M, Badimon L, Bugiardini R. The no-reflow phenomenon in the young and in the elderly. Int J Cardiol 222: 1122–1128, 2016. doi:10.1016/j.ijcard. 2016.07.209.
19. Chen WR, Chen YD, Tian F, Yang N, Cheng LQ, Hu SY, Wang J, Yang JJ, Wang SF, Gu XF. Effects of liraglutide on reperfusion injury in patients with ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging 9: e005146, 2016. doi:10.1161/CIRCIMAGING.116. 005146.
20. Chiang J, Kowada M, Ames A III, Wright RL, Majno G. Cerebral ischemia. III. Vascular changes. Am J Pathol 52: 455–476, 1968.
21. Cohen M, Boiangiu C, Abidi M. Therapy for ST-segment elevation myocardial infarction patients who present late or are ineligible for reperfusion therapy. J Am Coll Cardiol 55: 1895–1906, 2010. doi:10. 1016/j.jacc.2009.11.087.
22. Cuypers J, Matakas F. The effect of postischemic hyperemia on intracranial pressure and the no-reflow phenomenon. Acta Neuropathol 29: 73–84, 1974. doi:10.1007/BF00684393.
23. Dai W, Cheung E, Alleman RJ, Perry JB, Allen ME, Brown DA, Kloner RA. Cardioprotective effects of mitochondria-targeted peptide SBT-20 in two different models of rat ischemia/reperfusion. Cardiovasc Drugs Ther 30: 559–566, 2016. doi:10.1007/s10557-016-6695-9.
24. Dai W, Hale S, Kloner RA. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model. Int J Cardiol 236: 400–404, 2017. doi:10.1016/j.ijcard.2017.01.079.
25. Dalkara T, Arsava EM. Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis? J Cereb Blood Flow Metab 32: 2091–2099, 2012. doi:10.1038/jcbfm.2012.139.
26. Deipolyi AR, Wu O, Macklin EA, Schaefer PW, Schwamm LH, Gilberto Gonzalez R, Copen WA. Reliability of cerebral blood volume maps as a substitute for diffusion-weighted imaging in acute ischemic stroke. J Magn Reson Imaging 36: 1083–1087, 2012. doi:10.1002/jmri. 23740.
27. del Zoppo GJ, Sharp FR, Heiss WD, Albers GW. Heterogeneity in the penumbra. J Cereb Blood Flow Metab 31: 1836–1851, 2011. doi:10. 1038/jcbfm.2011.93.
28. De Silva DA, Fink JN, Christensen S, Ebinger M, Bladin C, Levi CR, Parsons M, Butcher K, Barber PA, Donnan GA, Davis SM; Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 40: 2872–2874, 2009. doi:10.1161/STROKEAHA.108.543595.
29. de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, Jenkins P, Thiele H, Stone GW. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J 38: 3502–3510, 2017. doi:10.1093/eurheartj/ehx414.
30. Dreier JP, Fabricius M, Ayata C, Sakowitz OW, William Shuttleworth C, Dohmen C, Graf R, Vajkoczy P, Helbok R, Suzuki M, Schiefecker AJ, Major S, Winkler MK, Kang EJ, Milakara D, Oliveira-Ferreira AI, Reiffurth C, Revankar GS, Sugimoto K, Den-gler NF, Hecht N, Foreman B, Feyen B, Kondziella D, Friberg CK, Piilgaard H, Rosenthal ES, Westover MB, Maslarova A, Santos E, Hertle D, Sánchez-Porras R, Jewell SL, Balança B, Platz J, Hinzman JM, Lückl J, Schoknecht K, Schöll M, Drenckhahn C, Feuerstein D, Eriksen N, Horst V, Bretz JS, Jahnke P, Scheel M, Bohner G, Rostrup E, Pakkenberg B, Heinemann U, Claassen J, Carlson AP, Kowoll CM, Lublinsky S, Chassidim Y, Shelef I, Friedman A, Brinker G, Reiner M, Kirov SA, Andrew RD, Farkas E, Güresir E, Vatter H, Chung LS, Brennan KC, Lieutaud T, Marinesco S, Maas AI, Sahuquillo J, Dahlem MA, Richter F, Herreras O, Boutelle MG, Okonkwo DO, Bullock MR, Witte OW, Martus P, van den Maagden-berg AM, Ferrari MD, Dijkhuizen RM, Shutter LA, Andaluz N, Schulte AP, MacVicar B, Watanabe T, Woitzik J, Lauritzen M, Strong AJ, Hartings JA. Recording, analysis, and interpretation of spreading depolarizations in neurointensive care: review and recommendations of the COSBID research group. J Cereb Blood Flow Metab 37: 1595–1625, 2017. doi:10.1177/0271678X16654496.
31. Errill EW. Rheology of blood. Physiol Rev 49: 863–888, 1969. doi:10. 1152/physrev.1969.49.4.863.
32. Fischer EG, Ames A III. Studies on mechanisms of impairment of cerebral circulation following ischemia: effect of hemodilution and perfusion pressure. Stroke 3: 538–542, 1972. doi:10.1161/str.3.5.538.
33. Fischer EG, Ames A III, Hedley-Whyte ET, O’Gorman S. Reassessment of cerebral capillary changes in acute global ischemia and their relationship to the “no-reflow phenomenon”. Stroke 8: 36–39, 1977. doi:10.1161/str.8.1.835156.
34. Fokkema ML, Vlaar PJ, Vogelzang M, Gu YL, Kampinga MA, de Smet BJ, Jessurun GA, Anthonio RL, van den Heuvel AF, Tan ES, Zijlstra F. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial. Circ Cardiovasc Interv 2: 323–329, 2009. doi:10.1161/CIRCINTERVENTIONS.109.858977.109. 858977.
35. Galiuto L, Garramone B, Scarà A, Rebuzzi AG, Crea F, La Torre G, Funaro S, Madonna M, Fedele F, Agati L; AMICI Investigators. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J Am Coll Cardiol 51: 552–559, 2008. doi:10.1016/j.jacc.2007. 09.051.
36. Garcia JH, Liu KF, Yoshida Y, Chen S, Lian J. Brain microvessels: factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat). Am J Pathol 145: 728–740, 1994.
37. González RG. Imaging-guided acute ischemic stroke therapy: from “time is brain” to “physiology is brain”. AJNR Am J Neuroradiol 27: 728–735, 2006.
38. González RG, Copen WA, Schaefer PW, Lev MH, Pomerantz SR, Rapalino O, Chen JW, Hunter GJ, Romero JM, Buchbinder BR, Larvie M, Hirsch JA, Gupta R. The Massachusetts General Hospital acute stroke imaging algorithm: an experience and evidence based approach. J Neurointerv Surg 5, Suppl 1: i7–i12, 2013. doi:10.1136/neurintsurg-2013-010715.
39. Goodwin AT, Amrani M, Gray CC, Chester AH, Yacoub MH. Inhibition of endogenous endothelin during cardioplegia improves low coronary reflow following prolonged hypothermic arrest. Eur J Cardio-thorac Surg 11: 981–987, 1997. doi:10.1016/S1010-7940(96)01115-3.
40. Granger DN, Kvietys PR. Reperfusion therapy: what’s with the obstructed, leaky and broken capillaries? Pathophysiology 24: 213–228, 2017. doi:10.1016/j.pathophys.2017.09.003.
41. 2 on cerebral blood volume, blood flow, and vascular mean transit time. Stroke 5: 630–639, 1974. doi:10.1161/str.5. 5.630.
42. Hale SL, Dae MW, Kloner RA. Hypothermia during reperfusion limits ‘no-reflow’ injury in a rabbit model of acute myocardial infarction. Cardiovasc Res 59: 715–722, 2003. doi:10.1016/S0008-6363(03)00456-5.
43. Hale SL, Herring MJ, Kloner RA. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size. J Am Heart Assoc 2: e004234, 2013. doi:10.1161/JAHA. 112.004234.
44. Hale SL, Kloner RA. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit. J Cardiovasc Pharmacol Ther 13: 226–232, 2008. doi:10.1177/1074248408320278.
45. Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O’Farrell FM, Buchan AM, Lauritzen M, Attwell D. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508: 55–60, 2014. doi:10.1038/nature13165.
46. Han X, Wu Y, Liu X, Ma L, Lv T, Sun Q, Xu W, Zhang S, Wang K, Wang W, Ma X, Liu H. Adiponectin improves coronary no-reflow injury by protecting the endothelium in rats with type 2 diabetes mellitus. Biosci Rep 37: BSR20170282, 2017. doi:10.1042/BSR20170282.
47. Hartings JA, Shuttleworth CW, Kirov SA, Ayata C, Hinzman JM, Foreman B, Andrew RD, Boutelle MG, Brennan KC, Carlson AP, Dahlem MA, Drenckhahn C, Dohmen C, Fabricius M, Farkas E, Feuerstein D, Graf R, Helbok R, Lauritzen M, Major S, Oliveira-Ferreira AI, Richter F, Rosenthal ES, Sakowitz OW, Sánchez-Porras R, Santos E, Schöll M, Strong AJ, Urbach A, Westover MB, Winkler MK, Witte OW, Woitzik J, Dreier JP. The continuum of spreading depolarizations in acute cortical lesion development: examining Leão’s legacy. J Cereb Blood Flow Metab 37: 1571–1594, 2017. doi:10.1177/0271678X16654495.
48. Herring MJ, Dai W, Hale SL, Kloner RA. Rapid induction of hypothermia by the ThermoSuit system profoundly reduces infarct size and anatomic zone of no reflow following ischemia-reperfusion in rabbit and rat hearts. J Cardiovasc Pharmacol Ther 20: 193–202, 2015. doi:10. 1177/1074248414535664.
49. Heusch G. The coronary circulation as a target of cardioprotection. Circ Res 118: 1643–1658, 2016. doi:10.1161/CIRCRESAHA.116.308640.
50. Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 38: 774–784, 2017. doi:10.1093/eurheartj/ehw224.
51. Heusch G, Kleinbongard P, Böse D, Levkau B, Haude M, Schulz R, Erbel R. Coronary microembolization: from bedside to bench and back to bedside. Circulation 120: 1822–1836, 2009. doi:10.1161/CIRCULATIONAHA.109.888784.
52. Heusch G, Skyschally A, Kleinbongard P. Coronary microembolization and microvascular dysfunction. Int J Cardiol 258: 17–23, 2018. doi:10.1016/j.ijcard.2018.02.010.
53. Hildebrandt HA, Patsalis PC, Al-Rashid F, Neuhäuser M, Rassaf T, Heusch G, Kahlert P, Kleinbongard P. Quantification and characteri-sation of released plaque material during bioresorbable vascular scaffold implantation into right coronary artery lesions by multimodality intracoronary imaging. EuroIntervention 12: 1481–1489, 2016. doi:10.4244/EIJ-D-15-00207.
54. Hossmann KA. Ischemia-mediated neuronal injury. Resuscitation 26: 225–235, 1993. doi:10.1016/0300-9572(93)90143-E.
55. Hussain H, Hassan A, Rahim B, Qureshi A. Prevalence and effect of ‘no reflow’ phenomenon following endovascular treatment related recanalization in patients with acute middle cerebral artery occlusion. Neurology 80, Suppl: P07.264, 2013.
56. Ishikawa M, Zhang JH, Nanda A, Granger DN. Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Front Biosci 9: 1339–1347, 2004. doi:10.2741/1330.
57. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni EA. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92: 1902–1910, 1995. doi:10. 1161/01.CIR.92.7.1902.
58. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 298: 229–317, 2012. doi:10.1016/B978-0-12-394309-5.00006-7.
59. Kamel H, Iadecola C. Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol 69: 576–581, 2012. doi:10.1001/archneurol.2011.3590.
60. Khosravi A, Rajabi D, Pourmoghaddas M, Roohi A, Esmaeili M. The role of manual thrombectomy in cardiovascular outcome among patients with total cutoff vessel myocardial infarction undergoing primary percutaneous coronary intervention. ARYA Atheroscler 13: 66–72, 2017.
61. Kim JY, Park J, Chang JY, Kim SH, Lee JE. Inflammation after ischemic stroke: the role of leukocytes and glial cells. Exp Neurobiol 25: 241–251, 2016. doi:10.5607/en.2016.25.5.241.
62. Kim MC, Cho JY, Jeong HC, Lee KH, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Hong YJ, Park HW, Kim JH, Jeong MH, Cho JG, Park JC, Seung KB, Chang K, Ahn Y. Long-term clinical outcomes of transient and persistent no reflow phenomena following percutaneous coronary intervention in patients with acute myocardial infarction. Korean Circ J 46: 490–498, 2016. doi:10.4070/kcj.2016.46. 4.490.
63. Kisler K, Nelson AR, Rege SV, Ramanathan A, Wang Y, Ahuja A, Lazic D, Tsai PS, Zhao Z, Zhou Y, Boas DA, Sakadžić S, Zlokovic BV. Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain. Nat Neurosci 20: 406–416, 2017. doi:10.1038/nn.4489.
64. Kleinbongard P, Böse D, Baars T, Möhlenkamp S, Konorza T, Schöner S, Elter-Schulz M, Eggebrecht H, Degen H, Haude M, Levkau B, Schulz R, Erbel R, Heusch G. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res 108: 344–352, 2011. doi:10.1161/CIRCRESAHA.110.235713.
65. Kleinbongard P, Konorza T, Böse D, Baars T, Haude M, Erbel R, Heusch G. Lessons from human coronary aspirate. J Mol Cell Cardiol 52: 890–896, 2012. doi:10.1016/j.yjmcc.2011.06.022.
66. Kloner RA. No-reflow phenomenon: maintaining vascular integrity. J Cardiovasc Pharmacol Ther 16: 244–250, 2011. doi:10.1177/1074248411405990.
67. Kloner RA, Alker KJ. The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion. Circulation 70: 513–521, 1984. doi:10.1161/01.CIR.70.3. 513.
68. Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54: 1496– 1508, 1974. doi:10.1172/JCI107898.
69. Kloner RA, Rude RE, Carlson N, Maroko PR, DeBoer LW, Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first? Circulation 62: 945–952, 1980. doi:10.1161/01.CIR.62.5.945.
70. Krug A, Du Mesnil de Rochemont W, Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res 19: 57–62, 1966. doi:10.1161/res.19.1.57.
71. Lansberg MG, Thijs VN, Bammer R, Kemp S, Wijman CA, Marks MP, Albers GW; DEFUSE Investigators. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 38: 2275–2278, 2007. doi:10.1161/STROKEAHA.106.480475.
72. Li Q, Zhao YG, Wang Z, Jiang HP, Liu WB, Cao BF. Effects of first high-dose atorvastatin loading in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Am J Ther 25: e291–e298, 2018. doi:10.1097/MJT.0000000000000370.
73. Liang T, Liu M, Wu C, Zhang Q, Lu L, Wang Z. Risk factors for no-reflow phenomenon after percutaneous coronary intervention in patients with acute coronary syndrome. Rev Invest Clin 69: 139–145, 2017.
74. Liu M, Liang T, Zhang P, Zhang Q, Lu L, Wang Z. hsCRP and ET-1 expressions in patients with no-reflow phenomenon after percutaneous coronary intervention. Pak J Med Sci 33: 920–925, 2017. doi:10.12669/pjms.334.13059.
75. Liu W, Zou Z, Jiang H, Li Q, Guo F, Wang Z, Zhu H. Clinical effect of preoperative high-dose atorvastatin against no-reflow after PCI. Exp Ther Med 13: 97–102, 2017. doi:10.3892/etm.2016.3910.
76. May JW Jr, Chait LA, O’Brien BM, Hurley JV. The no-reflow phenomenon in experimental free flaps. Plast Reconstr Surg 61: 256– 267, 1978. doi:10.1097/00006534-197802000-00017.
77. McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275: 772–782, 2015. doi:10.1148/radiol.15150025.
78. Mendelson SJ, Aggarwal NT, Richards C, O’Neill K, Holl JL, Prabhakaran S. Racial disparities in refusal of stroke thrombolysis in Chicago. Neurology 90: e359–e364, 2018. doi:10.1212/WNL. 0000000000004905.
79. Menees DS, Peterson ED, Wang Y, Curtis JP, Messenger JC, Rums-feld JS, Gurm HS. Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med 369: 901–909, 2013. doi:10. 1056/NEJMoa1208200.
80. Mohamed Mokhtarudin MJ, Payne SJ. Mathematical model of the effect of ischemia-reperfusion on brain capillary collapse and tissue swelling. Math Biosci 263: 111–120, 2015. doi:10.1016/j.mbs.2015.02. 011.
81. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schömig A, Kastrati A. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55: 2383–2389, 2010. doi:10.1016/j.jacc.2009.12.054.
82. Neely WA, Youmans JR. Anoxia of canine brain without damage. JAMA 183: 1085–1087, 1963. doi:10.1001/jama.1963.63700130004011a.
83. Nguyen J, Nishimura N, Fetcho RN, Iadecola C, Schaffer CB. Occlusion of cortical ascending venules causes blood flow decreases, reversals in flow direction, and vessel dilation in upstream capillaries. J Cereb Blood Flow Metab 31: 2243–2254, 2011. doi:10.1038/jcbfm. 2011.95.
84. Nishimura N, Rosidi NL, Iadecola C, Schaffer CB. Limitations of collateral flow after occlusion of a single cortical penetrating arteriole. J Cereb Blood Flow Metab 30: 1914–1927, 2010. doi:10.1038/jcbfm. 2010.157.
85. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebes-kind DS, Saver JL, Jovin TG; DAWN Trial Investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 378: 11–21, 2018. doi:10.1056/NEJMoa1706442.
86. Nong Y, Guo Y, Zhu X, Tomlin A, Bolli R. Abstract 16843: early preconditioning reduces no-reflow independently of infarct size in prolonged ischemia and benefits cardiac remodeling in mouse (Abstract). Circulation 136, Suppl 1: A16843, 2017.
87. Ober CD, Ober MC, Iancu AC. Serial transthoracic coronary Doppler shows complete reversibility of microvascular obstruction pattern at one month after reperfused acute myocardial infarction. Med Ultrason 19: 45–50, 2017. doi:10.11152/mu-941.
88. Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med 19: 1584–1596, 2013. doi:10.1038/nm.3407.
89. Ochocinska MJ, Zlokovic BV, Searson PC, Crowder AT, Kraig RP, Ljubimova JY, Mainprize TG, Banks WA, Warren RQ, Kindzelski A, Timmer W, Liu CH. NIH Workshop Report on the Trans-Agency Blood-Brain Interface Workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface. Fluids Barriers CNS 14: 12, 2017. doi:10.1186/s12987-017-0061-6.
90. O’Farrell FM, Mastitskaya S, Hammond-Haley M, Freitas F, Wah WR, Attwell D. Capillary pericytes mediate coronary no-reflow after myocardial ischaemia. eLife 6: e29280, 2017. doi:10.7554/eLife.29280.
91. Pang Z, Zhao W, Yao Z. Cardioprotective effects of nicorandil on coronary heart disease patients undergoing elective percutaneous coronary intervention. Med Sci Monit 23: 2924–2930, 2017. doi:10.12659/MSM.902324.
92. Papapostolou S, Andrianopoulos N, Duffy SJ, Brennan AL, Ajani AE, Clark DJ, Reid CM, Freeman M, Sebastian M, Selkrig L, Yudi MB, Noaman SQ, Chan W. Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multi-center Australian registry. EuroIntervention 14: 185–193, 2018. doi:10.4244/EIJ-D-17-00269.
93. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL; American Heart Association Stroke Council. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49: e46–e99, 2018. [Erratum in Stroke 49: e138, 2018. doi:10.1161/STR.0000000000000163.] doi:10.1161/STR. 0000000000000158.
94. Przyklenk K, Kloner RA. “Reperfusion injury” by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 64: 86–96, 1989. doi:10.1161/01.RES.64.1.86.
95. Reffelmann T, Hale SL, Dow JS, Kloner RA. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 108: 2911–2917, 2003. doi:10.1161/01. CIR.0000101917.80668.E1.
96. Reffelmann T, Kloner RA. Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? Am J Physiol Heart Circ Physiol 284: H1134–H1141, 2003. doi:10.1152/ajpheart.00563.2002.
97. Reffelmann T, Kloner RA. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol 283: H1099–H1107, 2002. doi:10.1152/ajpheart.00270.2002.
98. Ren F, Mu N, Zhang X, Tan J, Li L, Zhang C, Dong M. Increased platelet-leukocyte aggregates are associated with myocardial no-reflow in patients with ST elevation myocardial infarction. Am J Med Sci 352: 261–266, 2016. doi:10.1016/j.amjms.2016.05.034.
99. Rezkalla SH, Dharmashankar KC, Abdalrahman IB, Kloner RA. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol 23: 429–436, 2010. doi:10.1111/j. 1540-8183.2010.00561.x.
100. Rezkalla SH, Stankowski RV, Hanna J, Kloner RA. Management of no-reflow phenomenon in the catheterization laboratory. JACC Cardiovasc Interv 10: 215–223, 2017. [Erratum in JACC Cardiovasc Interv 10: 1282, 2017. doi:10.1016/j.jcin.2017.05.048.] doi:10.1016/j.jcin.2016.11. 059.
101. Ritter LS, Orozco JA, Coull BM, McDonagh PF, Rosenblum WI. Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke. Stroke 31: 1153– 1161, 2000. doi:10.1161/str.31.5.1153.
102. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW; AMISTAD-II Investigators. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 45: 1775–1780, 2005. doi:10.1016/j.jacc.2005.02.061.
103. Sabin P, Koshy AG, Gupta PN, Sanjai PV, Sivaprasad K, Velappan P, Vellikat Velayudhan R. Predictors of no-reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum. Indian Heart J 69, Suppl 1: S34–S45, 2017. doi:10. 1016/j.ihj.2016.12.012.
104. Şahinkuş S, Cakar M, Yaylacı S, Aydın E, Can Y, Kocayigit I, Osken A, Akdemir R, Gunduz H. Hematological markers of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention. Georgian Med News 254: 26–32, 2016.
105. Satogami K, Ino Y, Kubo T, Tanimoto T, Orii M, Matsuo Y, Ota S, Yamaguchi T, Shiono Y, Shimamura K, Katayama Y, Aoki H, Nishiguchi T, Ozaki Y, Yamano T, Kameyama T, Kuroi A, Kitabata H, Tanaka A, Hozumi T, Akasaka T. Impact of plaque rupture detected by optical coherence tomography on transmural extent of infarction after successful stenting in ST-segment elevation acute myocardial infarction. JACC Cardiovasc Interv 10: 1025–1033, 2017. doi:10.1016/j.jcin.2017. 01.044.
106. Sheehan HL, Davis JC. Renal ischaemia with failed reflow. J Pathol Bacteriol 78: 105–120, 1959. doi:10.1002/path.1700780112.
107. Shin HK, Dunn AK, Jones PB, Boas DA, Moskowitz MA, Ayata C. Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. J Cereb Blood Flow Metab 26: 1018–1030, 2006. doi:10.1038/sj.jcbfm.9600252.
108. Skyschally A, Amanakis G, Neuhäuser M, Kleinbongard P, Heusch G. Impact of electrical defibrillation on infarct size and no-reflow in pigs subjected to myocardial ischemia-reperfusion without and with ischemic conditioning. Am J Physiol Heart Circ Physiol 313: H871–H878, 2017. doi:10.1152/ajpheart.00293.2017.
109. Skyschally A, Walter B, Heusch G. Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning. Eur Heart J 34: 3314–3321, 2013. doi:10.1093/eurheartj/ehs434.
110. Soares BP, Tong E, Hom J, Cheng SC, Bredno J, Boussel L, Smith WS, Wintermark M. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke 41: e34–e40, 2010. doi:10. 1161/STROKEAHA.109.568766.
111. Soeda T, Higuma T, Abe N, Yamada M, Yokoyama H, Shibutani S, Ong DS, Vergallo R, Minami Y, Lee H, Okumura K, Jang IK. Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture. Eur Heart J Cardiovasc Imaging 18: 103–110, 2017. doi:10.1093/ehjci/jev341.
112. Sorensen AG, Copen WA, Østergaard L, Buonanno FS, Gonzalez RG, Rordorf G, Rosen BR, Schwamm LH, Weisskoff RM, Koroshetz WJ. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 210: 519–527, 1999. doi:10.1148/radiology.210.2.r99fe06519.
113. Stanimirovic D, Shapiro A, Wong J, Hutchison J, Durkin J. The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/ HCEC adhesion. J Neuroimmunol 76: 193–205, 1997. doi:10.1016/S0165-5728(97)00057-X.
114. Suda A, Namiuchi S, Kawaguchi T, Nihei T, Takii T, Saji K, Sugie T, Kato A, Shimokawa H. A simple and rapid method for identification of lesions at high risk for the no-reflow phenomenon immediately before elective coronary stent implantation. Heart Vessels 31: 1904–1914, 2016. doi:10.1007/s00380-016-0825-y.
115. Summers WK, Jamison RL. The no reflow phenomenon in renal ischemia. Lab Invest 25: 635–643, 1971.
116. Tagaya M, Haring HP, Stuiver I, Wagner S, Abumiya T, Lucero J, Lee P, Copeland BR, Seiffert D, del Zoppo GJ. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab 21: 835–846, 2001. doi:10.1097/00004647-200107000-00009.
117. Tian M, Zhu L, Lin H, Lin Q, Huang P, Yu X, Jing Y. Hsp-27 levels and thrombus burden relate to clinical outcomes in patients with ST-segment elevation myocardial infarction. Oncotarget 8: 73733–73744, 2017. doi:10.18632/oncotarget.17852.
118. Tsamatsoulis M, Kapelios CJ, Katsaros L, Vakrou S, Sousonis V, Sventzouri S, Michelinakis N, Perrea DN, Anastasiou-Nana M, Mal-liaras K. Cardioprotective effects of intracoronary administration of 4-chlorodiazepam in small and large animal models of ischemia-reperfusion. Int J Cardiol 224: 90–95, 2016. doi:10.1016/j.ijcard.2016.09.011.
119. Vakili H, Shirazi M, Charkhkar M, Khaheshi I, Memaryan M, Naderian M. Correlation of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with thrombolysis in myocardial infarction frame count in ST-segment elevation myocardial infarction. Eur J Clin Invest 47: 322–327, 2017. doi:10.1111/eci.12736.
120. Wade JG, Amtorp O, Sorensen SC. No-flow state following cerebral ischemia. Role of increase in potassium concentration in brain interstitial fluid. Arch Neurol 32: 381–384, 1975. doi:10.1001/archneur.1975. 00490480047005.
121. Wagdy S, Sobhy M, Loutfi M. Neutrophil/lymphocyte ratio as a predictor of in-hospital major adverse cardiac events, new-onset atrial fibrillation, and no-reflow phenomenon in patients with ST elevation myocardial infarction. Clin Med Insights Cardiol 10: 19–22, 2016. doi:10.4137/CMC.S35555.
122. Wang L, Liu G, Liu J, Zheng M, Li L. Effects of no-reflow phenomenon on ventricular systolic synchrony in patients with acute anterior myocardial infarction after percutaneous coronary intervention. Ther Clin Risk Manag 12: 1017–1022, 2016. doi:10.2147/TCRM.S107808.
123. Wang Y, Zhao Z, Rege SV, Wang M, Si G, Zhou Y, Wang S, Griffin JH, Goldman SA, Zlokovic BV. 3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice. Nat Med 22: 1050–1055, 2016. doi:10.1038/nm.4154.
124. Wang Z, Ren L, Lei L, Ye H, Peng J. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Acta Cardiol 71: 241–246, 2016. doi:10. 1080/AC.71.2.3141856.
125. Wang Z, Ren L, Liu N, Lei L, Ye H, Peng J. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Kardiol Pol 74: 1160–1166, 2016. doi:10.5603/KP. a2016.0065.
126. Wintermark M, Flanders AE, Velthuis B, Meuli R, van Leeuwen M, Goldsher D, Pineda C, Serena J, van der Schaaf I, Waaijer A, Anderson J, Nesbit G, Gabriely I, Medina V, Quiles A, Pohlman S, Quist M, Schnyder P, Bogousslavsky J, Dillon WP, Pedraza S. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 37: 979–985, 2006. doi:10.1161/01.STR. 0000209238.61459.39.
127. Wu KC, Kim RJ, Bluemke DA, Rochitte CE, Zerhouni EA, Becker LC, Lima JA. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. JAm Coll Cardiol 32: 1756–1764, 1998. doi:10.1016/S0735-1097(98) 00429-X.
128. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97: 765–772, 1998. doi: 10.1161/01.CIR.97.8.765.
129. Yemisci M, Gursoy-Ozdemir Y, Vural A, Can A, Topalkara K, Dalkara T. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 15: 1031–1037, 2009. doi:10.1038/nm.2022.
130. Yesin M, Çağdaş M, Kalçık M, Uluganyan M, Efe SC, Rencüzoğulları İ, Karabağ Y, Gürsoy MO, Karakoyun S. Comparison of syntax score and syntax score II to predict “no reflow phenome-non” in patients with ST-segment elevation myocardial infarction. Int J Cardiovasc Imaging 33: 1883–1889, 2017. doi:10.1007/s10554-017-1200-5.
131. Yetgin T, Uitterdijk A, Te Lintel Hekkert M, Merkus D, Krabben-dam-Peters I, van Beusekom HM, Falotico R, Serruys PW, Manint-veld OC, van Geuns RM, Zijlstra F, Duncker DJ. Limitation of infarct size and no-reflow by intracoronary adenosine depends critically on dose and duration. JACC Cardiovasc Interv 8: 1990–1999, 2015. doi:10.1016/j.jcin.2015.08.033.
132. Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and dysfunction of the blood-brain barrier. Cell 163: 1064–1078, 2015. doi:10.1016/j.cell.2015.10.067.